Cite
18F-Fluciclovine PET/CT performance in biochemical recurrence of prostate cancer: a systematic review
MLA
David M. Schuster, et al. “18F-Fluciclovine PET/CT Performance in Biochemical Recurrence of Prostate Cancer: A Systematic Review.” Prostate Cancer and Prostatic Diseases, vol. 24, no. 4, May 2021, pp. 997–1006. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....aa78013595e30ab82d1a857f6bb0a6ac&authtype=sso&custid=ns315887.
APA
David M. Schuster, Stephen B. Camper, Catriona M. Turnbull, Jason A. Efstathiou, Andrew Scarsbrook, Andy Kenwright, & Soroush Rais-Bahrami. (2021). 18F-Fluciclovine PET/CT performance in biochemical recurrence of prostate cancer: a systematic review. Prostate Cancer and Prostatic Diseases, 24(4), 997–1006.
Chicago
David M. Schuster, Stephen B. Camper, Catriona M. Turnbull, Jason A. Efstathiou, Andrew Scarsbrook, Andy Kenwright, and Soroush Rais-Bahrami. 2021. “18F-Fluciclovine PET/CT Performance in Biochemical Recurrence of Prostate Cancer: A Systematic Review.” Prostate Cancer and Prostatic Diseases 24 (4): 997–1006. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....aa78013595e30ab82d1a857f6bb0a6ac&authtype=sso&custid=ns315887.